Literature DB >> 15625244

The role of the small bowel in the regulation of circulating ghrelin levels and food intake in the obese Zucker rat.

Francesco Rubino1, Philippe Zizzari, Catherine Tomasetto, Marie-Therese Bluet-Pajot, Antonello Forgione, Michel Vix, Dominique Grouselle, Jacques Marescaux.   

Abstract

Circulating levels of ghrelin, a stomach peptide that promotes food intake, rise before and fall after meal. We aimed to investigate whether there is an independent contribution of the small bowel to the regulation of ghrelin and appetite. A duodenal-jejunal bypass (DJB) with preservation of normal gastric volume and exposure to nutrients was performed in 12-wk-old obese Zucker ZDF fa/fa rat. Food intake, weight gain, 48-h fasting, and 24-h refeeding levels of total and acylated ghrelin were measured. The DJB was challenged against gastric banding (GB), diet, and a sham operation in matched animals. Normal controls were age-matched Wistar rats, which underwent either DJB or a sham operation. The Zucker obese animals showed a paradoxical increase of acylated ghrelin levels after refeeding (+30% with respect to fasting levels; P = 0.001), an abnormality that was completely reversed only by the DJB (-30%; P = 0.01) but not after GB, diet, or sham operation. In obese rats, the DJB resulted in significantly less food intake and weight gain compared with both GB (P < 0.05) and sham operation (P < 0.01). In sharp contrast, the DJB did not alter food intake and weight gain in normal rats. The DJB does not physically restrict the flow of food but restores meal-induced suppression of acylated ghrelin and significantly reduces food intake in Zucker obese rats. These findings suggest an independent intestinal contribution to the regulation of the dynamic ghrelin response to eating and the possibility that defective signaling from the proximal bowel could be involved in the pathogenesis of obesity/hyperphagia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15625244     DOI: 10.1210/en.2004-1181

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  32 in total

1.  Roux-en-Y gastric bypass promotes expression of PDX-1 and regeneration of beta-cells in Goto-Kakizaki rats.

Authors:  Zhen Li; Hong-Ya Zhang; Lu-Xian Lv; Dong-Fei Li; Jing-Xing Dai; Ou Sha; Wen-Qiang Li; Yu Bai; Lin Yuan
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

2.  Sleeve gastrectomy plus side-to-side jejunoileal anastomosis for the treatment of morbid obesity and metabolic diseases: a promising operation.

Authors:  John Melissas; Anastasia Peppe; John Askoxilakis; Efstathios Dimitriadis; John Grammatikakis
Journal:  Obes Surg       Date:  2012-07       Impact factor: 4.129

Review 3.  Animal models in bariatric surgery--a review of the surgical techniques and postsurgical physiology.

Authors:  Raghavendra S Rao; Venkatesh Rao; Subhash Kini
Journal:  Obes Surg       Date:  2010-09       Impact factor: 4.129

Review 4.  A meta-analysis of short-term outcomes of patients with type 2 diabetes mellitus and BMI ≤ 35 kg/m2 undergoing Roux-en-Y gastric bypass.

Authors:  Wen-Sheng Rao; Cheng-Xiang Shan; Wei Zhang; Dao-Zhen Jiang; Ming Qiu
Journal:  World J Surg       Date:  2015-01       Impact factor: 3.352

5.  Bypassing the duodenum does not improve insulin resistance associated with diet-induced obesity in rodents.

Authors:  Tammy L Kindel; Paulo J F Martins; Stephanie M Yoder; Ronald J Jandacek; Randy J Seeley; David A D'Alessio; Silvana Obici; Patrick Tso
Journal:  Obesity (Silver Spring)       Date:  2010-10-28       Impact factor: 5.002

Review 6.  Metabolic surgery for the treatment of type 2 diabetes in patients with BMI <35 kg/m2: an integrative review of early studies.

Authors:  M Fried; G Ribaric; J N Buchwald; S Svacina; K Dolezalova; N Scopinaro
Journal:  Obes Surg       Date:  2010-06       Impact factor: 4.129

Review 7.  Role of the bypassed proximal intestine in the anti-diabetic effects of bariatric surgery.

Authors:  David E Cummings; Joost Overduin; Karen E Foster-Schubert; Molly J Carlson
Journal:  Surg Obes Relat Dis       Date:  2007 Mar-Apr       Impact factor: 4.734

Review 8.  Is type 2 diabetes a surgical disease?

Authors:  Mehran Anvari
Journal:  Can J Surg       Date:  2007-08       Impact factor: 2.089

9.  The economic impact of morbid obesity.

Authors:  Eldo E Frezza; Mitchell S Wachtel
Journal:  Surg Endosc       Date:  2009-01-30       Impact factor: 4.584

10.  An obese rat model of bariatric surgery with gastric banding.

Authors:  Yuichi Endo; Masayuki Ohta; Seiichiro Kai; Seigo Kitano
Journal:  Obes Surg       Date:  2007-06       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.